Skip to main content
Clinical Trials/NCT06298721
NCT06298721
Recruiting
Not Applicable

Improving Total Knee Arthroplasty Dissatisfaction at 1-year Through a Personalized Approach Focusing on PROMs Phenotypes: A Randomized Controlled Trial

The Cleveland Clinic1 site in 1 country300 target enrollmentMarch 12, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Knee Osteoarthritis
Sponsor
The Cleveland Clinic
Enrollment
300
Locations
1
Primary Endpoint
Satisfaction at 1 year
Status
Recruiting
Last Updated
11 months ago

Overview

Brief Summary

This study is a randomized controlled trial to assess whether the implementation of a TKA Personalized Outcome Prediction Tool to set expectation, in addition to targeted interventions to address patients with poor baseline mental health and poor physical function, improves satisfaction at 1-year (when compared to standard of care).

Detailed Description

The potential candidates for the study are patients scheduled for primary TKA. Scheduled patients will be sent an invitation letter detailing the study's objectives and design. Should they choose to take part, individuals will be requested to utilize MyChart for the completion of PROMs. The information gathered from these PROMs will play a pivotal role in assessing their suitability for inclusion in the study. Subsequently, once deemed eligible, our coordinator will arrange a convenient session to meticulously review and facilitate the signing of the informed consent form (enrollment visit). This enrollment visit will take place approximately 2-3 months prior to the scheduled surgery. Subsequently, enrolled patients will be randomized in a 1:1 ratio to: i) Standard of Care ii) Standard of Care + TKA Personalized Outcome Prediction Tool (Mental Health Screening/Intervention \& Physical Therapy Pre-surgery Assessments/Intervention) TKA Personalized Outcome Prediction Tool aids in setting expectations for surgery and the results (calculated from patient information and baseline PROMs) will be provided and discussed with the patients by the surgeon. The primary outcome of the study will be the proportion of patients who fail treatment, defined as patients who answer "no" to the PASS anchor question at 1-year postoperative. The treatment and control groups will be compared using a chi-square test between the randomized groups with p=0.05 as the threshold for statistical significance. We will follow the intent-to-treat principle, and patients assigned to the treatment/intervention arm will be analyzed as such regardless of his/her compliance with the intervention.

Registry
clinicaltrials.gov
Start Date
March 12, 2024
End Date
March 2027
Last Updated
11 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adult subject (Age \>18 and \< 80 years of age)
  • The subject is proficient in the English language
  • The patient is voluntarily prepared to sign the 'Informed Consent Form'
  • The patient is scheduled for a unilateral primary TKA
  • TKA PROMs Phenotypes with higher risk of dissatisfaction
  • Patient is willing and able to complete the protocol required follow-up

Exclusion Criteria

  • Patient requires simultaneous or staged bilateral knee replacements, staged \<90 days apart
  • Patients undergoing revision TKA
  • Inflammatory arthritis
  • History of infection in the joint undergoing TKA
  • Patient is considered a member of a protected population (e.g., prisoner, mentally incompetent, etc.)

Outcomes

Primary Outcomes

Satisfaction at 1 year

Time Frame: 1 year

Patient Acceptable Symptom State (PASS) anchoring question of: "Taking into account all the activity you have during your daily life, your level of pain and also your activity limitations and participation restrictions, do you consider the current state of your knee satisfactory?" to measure satisfaction

Study Sites (1)

Loading locations...

Similar Trials